Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05688410

Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Adults With an Opioid Use Disorder (EXPO; R33 Phase)

Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Adults With an Opioid Use Disorder (EXPO): A Randomized Trial (R33 Phase)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
198 (estimated)
Sponsor
Case Western Reserve University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This work will involve conducting a randomized trial that will evaluate preliminary efficacy of "assisted" rate cycling, voluntary rate cycling and psychotherapy for pain individually and in combination as adjunctive treatments on cravings (primary outcome) in adults with an opioid use disorder. The investigators will also evaluate the effects of "assisted" rate cycling, voluntary rate cycling and I-STOP on secondary outcomes including depression, anxiety and sleep.

Conditions

Interventions

TypeNameDescription
OTHERExerciseParticipants who are randomized to exercise will be perform exercise on stationary bikes. Participants randomized to "Voluntary Exercise" will exercise on a standard stationary bike where they will pedal at their voluntary rates. Participants randomized to "Assisted Exercise" will exercise on a special bike that assists them to pedal faster than they do voluntarily on their own ("assisted (exercise) bike").
BEHAVIORALPsychotherapy Pain and Addiction (I-STOP)Participants who are randomized to receive I-STOP will receive the "Self-regulation Treatment for Opioid addiction and Pain" (STOP) program modified for inpatients/residential drug treatment (I-STOP). I-STOP uses empirically validated pain psychotherapy approaches targeted to patients with an OUD using psycho-physiological self-regulation components and biofeedback with "Bio-dots".

Timeline

Start date
2023-02-10
Primary completion
2028-07-05
Completion
2028-07-05
First posted
2023-01-18
Last updated
2026-03-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05688410. Inclusion in this directory is not an endorsement.